Publications by authors named "J A Usher-Smith"
Objective: This study aimed to quantify public acceptability and anticipated uptake with risk stratification incorporated at three points on the bowel cancer screening pathway, compared with current screening in England.
Methods: We conducted an online population-based survey of 1,203 UK adults in 2024. The main outcome measures were overall acceptability of three strategies where risk stratification is introduced at 1) the point of eligibility, 2) the referral threshold and 3) the screening interval, compared with the current programme (screening as usual), and the acceptability of high- and low-risk screening practices at each point.
Article Synopsis
- NICE recommends additional breast screening and interventions for women in England at above-population risk for breast cancer.
- A review of GP referrals showed up to 20% of women lacked sufficient information for risk assessment, with over 25% assessed as near-population risk.
- Many women may miss out on preventative measures due to current systemic issues, highlighting the need for better data collection and risk assessment processes to address health inequalities.
Article Synopsis
- Multifactorial cancer risk prediction tools like CanRisk are being increasingly used in healthcare, but effectively communicating this risk information is challenging for healthcare professionals.
- A 13-month co-design process involved patients, the public, and healthcare professionals to develop a new CanRisk report after receiving feedback on the original.
- The revised report presents key information for individuals and healthcare professionals, including summaries, explanatory text, and visual aids, enhancing communication around cancer risk management.
Background And Objective: The Yorkshire Kidney Screening Trial (YKST) assessed the feasibility of adding abdominal noncontrast computed tomography (NCCT) to lung cancer screening to screen for kidney cancer and other abdominal pathology.
Methods: A prospective diagnostic study offered abdominal NCCT to 55-80-yr-old ever-smokers attending a UK randomised lung cancer screening trial (May 2021 to October 2022). The exclusion criteria were dementia, frailty, previous kidney/lung cancer, and computed tomography (CT) of the abdomen and thorax within previous 6 and 12 mo, respectively.